Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Roche Diagnostics cobas™ Liat SARS-CoV-2, Influenza A/B and RSV RT-PCR Assay Kit

Catalog No. 21200319 Shop All Roche Diagnostics Products
Click to view available options
:
This item is not returnable. View return policy
Order eligibility is based upon executed contractual agreement.
This item is not returnable. View return policy
Order eligibility is based upon executed contractual agreement.

The cobas™ liat SARS-CoV-2, Influenza A/B and RSV nucleic acid test for use on the cobas Liat System is a multiplex real-time polymerase chain reaction (PCR) test that detects and differentiates SARS-CoV-2, Influenza A, Influenza B and RSV in nasopharyngeal or anterior nasal swab specimens.

The cobas™ liat SARS-CoV-2, Influenza A/B and RSV Nucleic acid test for use on the cobas™ Liat™ System is an automated rapid multiplex real-time, reverse transcriptase polymerase chain reaction (RT-PCR) test intended for the simultaneous qualitative detection and differentiation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza A, and influenza B virus, and respiratory syncytial virus nucleic acid in nasopharyngeal swab (NPS) and anterior nasal swab (ANS) specimens from individuals with signs and symptoms of respiratory tract infection. This test has no age restrictions

Specifications

Content And Storage

3 sets of positive and negative controls per kit

Control Sets

integrated sample processing control, positive and negative controls

CPT Code

87637 (for assay)

CE Marker

Yes

Clia Complexity

Waived (EUA)

Detectable Analytes

SARS-CoV-2, Influenza A and B, Rubella Virus Antibodies

Detection Method

RT-PCR

DoA Calibrators

No

Format

Kit

Sample Type

For assay: nasaopharyngeal or anterior nasal

Sensitivity

For assay: Influenza A, B, RSV = 100% positive agreement; SARS-CoV-2=96.7% positive agreement

Type

Control

Disposable

Single-use

For Use With (Application)

Detection of SARS-CoV-2, Influenza A/B, and RSV

For Use With (Equipment)

Used with the cobas™ liat analyzer to validate lots or run control tests

Product Line

cobas™

Quantity

1

Specificity

For assay: SARS-CoV-2=96.7% negative agreement; Influenza A = 98.1% negative agreement; Influenza B = 97.7% negative agreement; RSV = 97.2% negative agreement

Analysis Time

20 min.

Dimensions (L x W x H)

6.1 x 10 x 1.4 in.

Weight (English)

0.1 lb.

Form

Ready-to-Use (RTU)

Show More Show Less

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.